Antibody-based drugs often become too thick to be injected at high concentrations. Now, new research can explain why this happens—knowledge that could eventually lead to easily injectable medications.

The lower hinge of immunoglobulin G (IgG), an overlooked part of the antibody, acts as a structural and functional control ...

A research team engineered a rigid, nanometer-scale protein module to address the challenge of measuring antibody flexibility ...

As biological data volume continues to grow, sequence-based AI is poised to become the dominant discovery layer across pharma ...

Antibody-based drugs often become too thick to be injected at high concentrations. Now, new research can explain why this happens—knowledge that could eventually lead to easily injectable medications.

From penetrating solid tumors to new success rates for de novo design, the next wave of antibody therapies aims to transform the clinic.

Australian researchers have developed a powerful new way to target deadly, drug-resistant bacteria by designing antibodies ...

Alfa Cytology offers specialized radiolabeling and antibody-radionuclide conjugate development to advance radiopharmaceutical ...

Researchers have identified a promising new weapon against triple-negative breast cancer, one of the most aggressive forms of ...